Gene · 7086
Papers3,154
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,154
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Fermented Wheat Germ Extract Contains Protein Components Active against NSCLC Xenografts In Vivo. | Curr Issues Mol Biol | 2023 | 37754232 | PubTator, text mining | PubMed |
| Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma. | Cell Death Dis | 2023 | 37749143 | PubTator, text mining | PubMed |
| Dynamic Protonation States Underlie Carbene Formation in ThDP-Dependent Enzymes: A Theoretical Study. | J Phys Chem B | 2023 | 37748048 | PubTator, text mining | PubMed |
| Stem cell factor modulates HIF-1α levels and diminishes 5-FU sensitivity in 5-FU resistant pancreatic cells by altering the anabolic glucose metabolism. | J Biochem Mol Toxicol | 2023 | 37718545 | PubTator, text mining | PubMed |
| Thiamine administration may increase survival benefit in critically ill patients with myocardial infarction. | Front Nutr | 2023 | 37706212 | PubTator, text mining | PubMed |
| Sulforaphane rewires central metabolism to support antioxidant response and achieve glucose homeostasis. | Redox Biol | 2023 | 37703668 | PubTator, text mining | PubMed |
| Lipid and glucose metabolism in senescence. | Front Nutr | 2023 | 37680899 | PubTator, text mining | PubMed |
| Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity. | Front Immunol | 2023 | 37675104 | PubTator, text mining | PubMed |
| Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. | J Inflamm Res | 2023 | 37663754 | PubTator, text mining | PubMed |
| Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. | Heliyon | 2023 | 37662778 | PubTator, text mining | PubMed |
| Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice. | Exp Mol Med | 2023 | 37653031 | PubTator, text mining | PubMed |
| Multi-omics analysis of fecal samples in colorectal cancer Egyptians patients: a pilot study. | BMC Microbiol | 2023 | 37644393 | PubTator, text mining | PubMed |
| Micronutrients in Pregnancy after Bariatric Surgery: A Narrative Review. | J Clin Med | 2023 | 37629473 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| The Impact of Viral Infection on the Chemistries of the Earth's Most Abundant Photosynthesizes: Metabolically Talented Aquatic Cyanobacteria. | Biomolecules | 2023 | 37627283 | PubTator, text mining | PubMed |
| Transcriptome profiling of A549 non-small cell lung cancer cells in response to Trichinella spiralis muscle larvae excretory/secretory products. | Front Vet Sci | 2023 | 37601754 | PubTator, text mining | PubMed |
| Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. | Arch Toxicol | 2023 | 37597078 | PubTator, text mining | PubMed |
| Long-term health care use and diagnosis after hospitalization for COVID-19: a retrospective matched cohort study. | CMAJ Open | 2023 | 37582621 | PubTator, text mining | PubMed |
| Machine learning-based integration develops a neutrophil-derived signature for improving outcomes in hepatocellular carcinoma. | Front Immunol | 2023 | 37575244 | PubTator, text mining | PubMed |
| Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. | Front Immunol | 2023 | 37575240 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7086/papers?page=12